National trends in the treatment of attention deficit hyperactivity disorder

American Journal of Psychiatry

Volumn 160, Issue 6, 2003, Pages 1071-1077

  Olfson, Mark ^a   Gameroff, Marc J ^b  

^a Columbia University ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; HEALTH INSURANCE; HEALTH PRACTITIONER; HEALTH SURVEY; HUMAN; LOWEST INCOME GROUP; OUTPATIENT; POPULATION ABUNDANCE; PRIORITY JOURNAL; TIME SERIES ANALYSIS; AMBULATORY CARE; COMPARATIVE STUDY; DRUG UTILIZATION; EPIDEMIOLOGY; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH MAINTENANCE ORGANIZATION; MALE; MENTAL HEALTH SERVICE; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; PSYCHOTHERAPY; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

CENTRAL STIMULANT AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; AMBULATORY CARE; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE; DRUG UTILIZATION; FEMALE; HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; MALE; MENTAL HEALTH SERVICES; OFFICE VISITS; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 0038826242     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.6.1071     Document Type: Article

References (41)

1. Goldman LS, Genel M, Bezman RJ, Slanetz PS (Council on Scientific Affairs, American Medical Association): Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998; 279:1100-1107
2. Elia J, Ambrosini PJ, Rapoport JL: Treatment of attention-deficit- hyperactivity disorder. N Engl J Med 1999; 340:780-788
3. Gillberg C, Melander H, von Knorring AL, Janols LO, Thernlund G, Hagglof B, Eidevall-Wallin L, Gustafsson P: Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 1997; 54:857-864
4. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999; 56:1073-1086
5. Pelham WE, Wheeler T, Chronis A: Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. J Clin Child Psychol 1988; 27:190-205
6. Horn WF, Ialongo NS, Pascoe JM, Greenberg G, Packard T, Lopez M, Wagner A, Puttler L: Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children. J Am Acad Child Adolesc Psychiatry 1991; 30:233-240
7. Pelham WE, Gnagy EM, Greiner AR, Hoza B, Hinshaw SP, Swanson JM, Simpson S, Shapiro C, Bukstein O, Baron-Myak C, McBurnett K: Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychol 2000; 28:507-525
8. Jensen PS, Hinshaw SP, Swanson JM, Greenhill LL, Conners CK, Arnold LE, Abikoff HB, Elliott G, Hechtman L, Hoza B, March JS, Newcorn JH, Severe JB, Vitiello B, Wells K, Wigal T: Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr 2001; 22:60-73
9. Jensen PS, Kettle L, Roper MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ, Payne JD: Stimulant treatment for children: a community perspective: commentary. J Am Acad Child Adolesc Psychiatry 2000; 39:984-987
10. Rappley MD, Gardiner JC, Jetton JR, Houang RT: The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med 1996; 150:558-559
11. Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ, Payne JD: Are stimulants overprescribed? treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry 1999; 38:797-804
12. Angold A, Erklani A, Egger HL, Costello EJ: Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 2000; 39:975-984
13. Morrow RC, Morrow AL, Haislip G: Methylphenidate in the United States, 1990 through 1995 (letter). Am J Public Health 1998; 88:1121
14. Batoosingh KA: Ritalin prescriptions triple over last 4 years. Clin Psychiatr News 1995; 23:1-2
15. Hoagwood K, Kelleher KJ, Feil M, Comer DM: Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 2000; 39:198-206
16. Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA: Psychotherapeutic medication patterns for youths with attention-deficit/ hyperactivity disorder. Arch Pediatr Adolesc Med 1999; 153:1257-1263
17. Safer DJ, Magder LS: Stimulant treatment in Maryland public schools. Pediatrics 2000; 106:533-539
18. Zito JM, Riddle MA, Safer DJ, Magder LS: Pharmacoepidemiology of youth with treatments for mental disorders (abstract). Psychopharmacol Bull 1995; 31:540
19. Rushton JL, Whitmire JT: Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med 2001; 155:560-565
20. Hoagwood K, Jensen P, Feil M, Vitiello B, Bhatara V: Medication management in pediatric practice settings: a national perspective. J Dev Behav Ped 2000; 21:322-331
21. Peak T, Barusch A: Managed care: a critical review. J Health Soc Policy 1999; 11:21-36
22. Edwards WS, Berlin M: National Medical Expenditure Survey: Questionnaires and Data Collection Methods for the Household Survey and Survey of American Indians and Alaska Natives: DHHS Publication PHS 89-3450. Washington, DC, US Department of Health and Human Services, 1989
23. Cohen J: Design and Methods of the Medical Expenditure Panel Survey Household Component: MEPS Methodology Report 1: AHCPR Publication 97-0026. Rockville, Md, Agency for Health Care Policy and Research, 1997
24. Cohen S, DiGaetano R, Waksberg J: Sample Design of the 1987 Household Survey: National Medical Expenditure Survey Methods 3: AHCPR Publication 91-0037. Rockville, Md, Agency for Health Care Policy and Research, 1991
25. Shah BV, Barnwell BG, Bieler GS: SUDAAN User's Manual, Release 7.5. Research Triangle Park, NC, Research Triangle Institute, 1997
26. McEvoy GK (ed): American Hospital Formulary Service-Drug Information 96. Bethesda, Md, American Society of Health-System Pharmacists, 1996
27. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME, Lahey BB, Bourdon K, Jensen PS, Bird HR, Canino G, Regier DA: The NIMH Diagnostic Interview Schedule for Children, version 2.3 (DISC-2.3): description, acceptability, prevalence rates, and performance in the MECA study (Methods for the Epidemiology of Child and Adolescent Mental Disorders Study). J Am Acad Child Adolesc Psychiatry 1996; 35:865-877
28. Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J: Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry 1996; 35:319-324
29. Bird HR, Canino G, Rubio-Stipec M, Gould MS, Ribera J, Sesman M, Woodbury M, Huertas-Goldman S, Pagan A, Sanchez-Lacay A, Moscoso M: Estimates of the prevalence of childhood mal-adjustment in a community survey in Puerto Rico: the use of combined measures. Arch Gen Psychiatry 1988; 45:1120-1126
30. Swanson JM, McBurnett K, Christian DL, Wigal T: Stimulant medications and the treatment of children with ADHD, in Advances in Clinical Child Psychology, vol 17. Edited by Ollendick TH, Prinz RJ. New York, Plenum, 1995, pp 265-307
31. Schlitt J: State initiatives to support school-based health centers: a national survey. J Adolesc Health 1995; 17:68-76
32. Burns BJ, Costello EJ, Angold A, Tween D, Stangl D, Farmer EM, Erkanli A: Children's mental health service use across service sectors. Health Aff (Millwood) 1995; 14:147-159
33. Connors C: Symptom patterns in hyperkinetic, neurotic, and normal children. Child Dev 1970; 41:667-682
34. Connors CK: Connors Rating Scales - Revised, in The Use of Psychological Testing for Treatment Planning and Outcomes Assessment, 2nd edition. Edited by Maruish ME. Hillsdale, NJ, Lawrence Erlbaum Associates, 1999, pp 467-495
35. Rose VL: NIH issues consensus state on attention-deficit/hyperactivity disorder. Am Fam Physician 1999; 2645-2646
36. American Academy of Pediatrics, Committee on Quality Improvement: Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000; 105:1158-1070
37. Health Care Plan Design and Cost Trends - 1988 through 1997. Washington, DC, Hay Group, May 1998
38. Hennessy KD, Green-Hennessy S: An economic and clinical rationale for changing utilization review practices for outpatient psychotherapy. J Ment Health Admin 1997; 24:340-349
39. Connor DF, Fletcher KE, Swanson JM: A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1999; 38:1551-1559
40. Kappagoda C, Schell DN, Hanson RM, Hutchins P: Clonidine overdose in childhood: implications of increased prescribing. J Paediatr Child Health 1998; 34:501-502
41. Broderick-Cantwell JJ: Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients. J Am Acad Child Adolesc Psychiatry 1999; 38:95-98